News
dementia, stroke and certain cancers. GLP-1 weight loss drugs, such as Wegovy and Zepbound, have helped millions of people shed weight and curb food cravings. But they create additional health ...
With approximately one million people in the UK living with dementia, and a third undiagnosed, the charity's recent study reveals that over 60% of British adults are unaware that visual difficulties ...
(Pic Credit: Supplied) Nana started misplacing items; she would lose ... a lot of weight. Feeling powerless and alone, I yearned for community. I wanted to tackle the stigma around dementia ...
Fat Friends aired on ITV from 2000 to 2005 and featured a number of stars who went on to have incredibly successful careers.
3d
Oprah Daily on MSNDoes Combining Hormone Therapy and a GLP-1 Boost Your Menopausal Weight Loss? Here's What the Research SaysMenopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...
Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...
Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...
2don MSN
A new analysis suggests that a diet high in ultraprocessed foods may lead microplastics to accumulate in the brain, which may ...
6don MSN
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
3d
The Healthy @Reader's Digest on MSNNew Study Says 32% of People with Dementia Experience This Symptom, TooThe link is a bit of a catch-22, but new research says addressing this very common symptom of aging could also help manage ...
What many people don’t know is that hearing loss increases the potential risk of dementia. Dr. Andy Tubertini, an audiologist with Coastal Alabama Hearing, sits down with Lenise Ligon to give ...
Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Shelby Knowles/Bloomberg/Getty Images Zepbound outperformed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results